Skip to main content
Greg Licholai

Gregory P. Licholai

Lecturer, Yale School of Management; Chief Medical and Chief Innovation Officer, ICON plc

Greg teaches Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Chief Innovation Officer at ICON plc, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He is co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained in neurosurgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on several healthcare company boards and medical advisory boards. Greg writes about innovation for Forbes.

Education

  • MBA, Harvard University, 2000
  • MD, Yale University School of Medicine, 1995

Selected Works

Articles

Selected Books

  • Introduction to Medical Software: Foundations for Digital Health, Devices, and Diagnostics
    G. P. Licholai, X. Papademetris, and A. N. Quraishi
    2022

Yale SOM Case Studies

  • Population Health Management at Atrius
    Yale School of Management Case Study
    2016
     
  • Nomad Health and the Disruption of Physician Staffing Services
    Yale School of Management Case Study
    2017
     
  • Cobalt and the Rise of Digital Health
    Yale School of Management Case Study
    2018
     
  • Everlywell and Creating Access to Lab Testing
    Yale School of Management Case Study
    2019
     
  • Talkspace and digital health market dynamics
    Yale School of Management Case Study
    2019
     
  • Medical Tourism, Neurosurgery and Singapore’s Largest Health System
    Yale School of Management Case Study
    2018
     
  • CRISPR Therapeutics and Editing the Human Genome
    Yale School of Management Case Study
    2018
     
  • The Health Data Insurgency
    Yale School of Management Case Study
    2020